Wenbin Wang
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 7
- RNA Research and Splicing 3
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 3
- Co-authors
- Wendong Li (7 shared papers)Mulin Liu (7 shared papers)Shuanhu Wang (7 shared papers)Xiao Yuan (8 shared papers)Chenglong Li (4 shared papers)Xiaolong Du (5 shared papers)Nan Hu (3 shared papers)Hao Zhuang (3 shared papers)
- Journals
- Journal of Translational Medicine (3 papers)Thrombosis Research (2 papers)Microvascular Research (2 papers)BioMed Research International (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Wenbin Wang
35 papers receiving 863 citations
Peers
Comparison fields: 5 of 80
- Internal Medicine 92
- Cancer Research 408
- Molecular Biology 479
- Hematology 47
- Molecular Medicine 17
Countries citing papers authored by Wenbin Wang
This map shows the geographic impact of Wenbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenbin Wang more than expected).
Fields of papers citing papers by Wenbin Wang
This network shows the impact of papers produced by Wenbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenbin Wang. The network helps show where Wenbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 72 | |
| 2 | 2020 | 63 | |
| 3 | 2018 | 61 | |
| 4 | 2015 | 60 | |
| 5 | 2016 | 57 | |
| 6 | 2019 | 49 | |
| 7 | 2014 | 48 | |
| 8 | 2015 | 46 | |
| 9 | 2018 | 33 | |
| 10 | 2014 | 31 | |
| 11 | 2016 | 31 | |
| 12 | 2015 | 31 | |
| 13 | 2020 | 30 | |
| 14 | 2019 | 28 | |
| 15 | 2016 | 26 | |
| 16 | 2018 | 25 | |
| 17 | 2017 | 25 | |
| 18 | 2022 | 19 | |
| 19 | 2019 | 19 | |
| 20 | 2023 | 16 |
About Wenbin Wang
Wenbin Wang is a scholar working on Molecular Biology, Cancer Research, Surgery, Internal Medicine and Pathology and Forensic Medicine, having authored 35 papers that have together received 870 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (7 papers), RNA modifications and cancer (7 papers), MicroRNA in disease regulation (6 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Cancer, Lipids, and Metabolism (3 papers), RNA Research and Splicing (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Internal Medicine (92 citations), Cancer Research (408 citations), Molecular Biology (479 citations), Hematology (47 citations) and Molecular Medicine (17 citations). Wenbin Wang has collaborated with scholars based in China and United States. Frequent co-authors include Wendong Li, Mulin Liu, Shuanhu Wang, Xiao Yuan, Chenglong Li, Xiaolong Du, Nan Hu, Hao Zhuang, Xiaoqiang Li and Qingyou Meng. Their work appears in journals such as Journal of Translational Medicine, Thrombosis Research, Microvascular Research, BioMed Research International and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.